Sumatriptan Succinate Tablets
SOL #: SPE2D223R0003Award Notice
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Carole Park, AU-ACT, Australia
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Nov 21, 2022
2
Last Updated
Jul 3, 2025
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Modification SPE2D223D0009 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Contract Award for Sumatriptan Succinate Tablets
People
Points of Contact
Phyllis DaraioPRIMARY
Files
Versions
Version 9
Award Notice
Posted: Jul 3, 2025
Version 8
Award Notice
Posted: May 16, 2024
Version 7Viewing
Award Notice
Posted: Aug 24, 2023
Version 6
Award Notice
Posted: Jul 25, 2023
Version 5
Solicitation
Posted: Feb 3, 2023
Version 4
Solicitation
Posted: Jan 4, 2023
Version 3
Solicitation
Posted: Dec 15, 2022
Version 2
Solicitation
Posted: Dec 14, 2022
Version 1
Pre-Solicitation
Posted: Nov 21, 2022